severe sepsis

Related by string. Severe sepsis * SEVERE . se vere . Severe : Severe Acute Respiratory Syndrome . severe acute respiratory . severe abdominal pain . severe stomach cramps . severe burns . severe thunderstorm warnings / Sepsis . Sepsi : sepsis bloodstream infection . neonatal sepsis . tuberculosis TB sepsis . sepsis septic . sepsis pneumonia . bacterial sepsis * Severe sepsis afflicts *

Related by context. All words. (Click for frequent words.) 68 sepsis 64 lupus nephritis 63 acute coronary syndromes 62 ADHF 62 invasive aspergillosis 61 NYHA Class II 61 Sepsis 61 acute coronary syndrome 60 HCV infection 60 non metastatic osteosarcoma 60 cSSSI 60 idiopathic pulmonary fibrosis IPF 60 acute myocardial infarction AMI 60 leukemia ALL 60 CMV infection 60 invasive candidiasis 60 atherothrombotic events 60 candidemia 59 CMV disease 59 COPD 59 leukemia AML 59 Xigris 59 HCV infections 59 acute ischemic stroke 59 Hepatocellular Carcinoma HCC 59 atherothrombotic disease 59 cardiogenic shock 58 chronic lymphocytic leukemia CLL 58 hematological malignancy 58 VTE 58 chronic HCV infection 58 acute coronary syndromes ACS 58 multiple myeloma 58 chronic HCV 58 decompensated heart failure 58 superficial bladder cancer 58 Ilaris 58 diabetic nephropathy 58 hepatorenal syndrome 58 myelofibrosis 58 S. aureus infections 58 metastatic renal cell carcinoma 58 virus HCV infection 58 nonsmall cell lung cancer 58 malignant pleural mesothelioma 58 mRCC 58 indolent NHL 57 micafungin 57 Severe VOD 57 relapsed multiple myeloma 57 aHUS 57 ischemic complications 57 RSV infections 57 hepatocellular carcinoma 57 acute myelogenous leukemia AML 57 colorectal cancer CRC 57 Clostridium difficile infection 57 levosimendan 57 invasive MRSA infections 57 acute myocardial infarction 57 hepatitis C genotype 57 SHPT 57 stable angina 57 acute myeloid leukemia AML 57 recurrent ovarian cancer 57 invasive breast cancer 57 immune thrombocytopenic purpura ITP 57 recurrent myocardial infarction 57 vWD 57 bloodstream infection 57 bendamustine 57 heterozygous FH 57 CDAD 56 PAOD 56 hepatocellular cancer 56 chronic ITP 56 reinfarction 56 interstitial pneumonia 56 Lung transplantation 56 metastatic malignant melanoma 56 elotuzumab 56 terlipressin 56 renal dysfunction 56 hemodialysis patients 56 cardiovascular hospitalization 56 Idiopathic Pulmonary Fibrosis IPF 56 autoantibody positive 56 acute decompensated heart 56 atrial fibrillation AF 56 myelodysplastic syndrome MDS 56 metastatic malignant 56 VT VF 56 GvHD 56 Altastaph 56 medullary thyroid cancer 56 venous thromboembolic events 56 elevated triglyceride levels 56 chronic HBV 56 Diabetic Macular Edema 56 allogeneic bone marrow 56 iron overload 56 NATRECOR ® 56 OHR/AVR# 56 bucindolol 56 immunocompromised patients 56 sunitinib 56 oxypurinol 56 rotavirus diarrhea 56 cardiovascular disease CVD 56 systemic lupus erythematosus SLE 56 ponatinib 56 thrombotic thrombocytopenic purpura TTP 56 hepatitis C HCV 56 immunocompetent patients 56 rFVIIa 56 HSCT 56 Velcade bortezomib 56 atrial fibrillation AFib 56 PSVT 56 Doxil ® 55 liver metastases 55 hepatocellular carcinoma HCC 55 phase IIb trial 55 Staphylococcus aureus infections 55 ximelagatran 55 carcinoid tumors 55 pancreatic NET 55 upper gastrointestinal bleeding 55 CRBSIs 55 thrombotic complications 55 recurrent VTE 55 acute renal failure 55 metastatic lung cancer 55 AA Amyloidosis 55 RSV infection 55 NSCLC 55 acute STEMI 55 S. aureus bacteremia 55 Acute Myelogenous Leukemia AML 55 postoperative atrial fibrillation 55 Haptoglobin 55 acute myocardial infarctions 55 severe aortic stenosis 55 Renal Cell Carcinoma RCC 55 pulmonary embolism PE 55 AA amyloidosis 55 malignant neoplasms 55 recurrent glioblastoma multiforme 55 hypereosinophilic syndrome 55 Myelodysplastic Syndrome MDS 55 pneumococcal infection 55 HoFH 55 Acute Radiation Syndrome ARS 55 virological response 55 non squamous NSCLC 55 PTLD 55 GISTs 55 ischemic cardiomyopathy 55 idiopathic thrombocytopenic purpura ITP 55 Pseudomonas aeruginosa infections 55 invasive fungal infection 55 staphylococcal infections 55 pneumococcal pneumonia 55 eculizumab 55 refractory angina 55 HER2 positive breast cancer 55 metastatic kidney 55 ATACAND 55 Myelodysplastic syndromes 55 familial hypercholesterolemia 55 venous thromboembolism VTE 55 pulmonary arterial hypertension 55 cardiovascular disease 55 metastatic melanoma 55 metastatic breast cancer 55 IV NSCLC 55 unstable angina 55 lumiliximab 55 colorectal cancer 55 EXJADE 55 BARACLUDE ® 55 chronic GVHD 55 mCRC 55 Alemtuzumab 55 respiratory viral infections 55 nosocomial pneumonia 55 Amrubicin 55 HuLuc# 55 thrombocytopenic 55 azacitidine 55 recurrent stroke 55 HeFH 55 Acute Myeloid Leukaemia AML 55 adult chronic ITP 55 deferiprone 55 adrenal insufficiency 55 ischemic stroke 55 amphotericin B 55 ZYVOX 55 pancreatic adenocarcinoma 54 systemic fungal infections 54 T2DM 54 IV metastatic melanoma 54 chronic HBV infection 54 alemtuzumab treated 54 C. difficile infection 54 glufosfamide 54 Follicular lymphoma 54 coronary revascularization 54 standard chemotherapy regimen 54 ruptured aneurysms 54 Hodgkin lymphoma NHL 54 thrombocytopenic patients 54 systemic amyloidosis 54 antithrombotic therapy 54 acutely decompensated heart 54 lymphoma CTCL 54 hematologic disorders 54 leukemia CLL 54 renal cell carcinoma 54 AAT deficiency 54 graft dysfunction 54 diastolic heart 54 Nesiritide 54 docetaxel chemotherapy 54 Fabry Disease 54 smoldering myeloma 54 invasive fungal infections 54 PICSO ® 54 ALN TTR 54 NATRECOR R 54 Severe Sepsis 54 Acute myeloid leukemia 54 thrombotic events 54 secondary hyperparathyroidism 54 Chronic lymphocytic leukemia 54 dyslipidaemia 54 neurogenic orthostatic hypotension 54 Clostridium difficile associated 54 MPS VI 54 follicular lymphoma 54 ketolide antibiotic 54 macrovascular events 54 refractory AML 54 DLBCL 54 myocardial infarction MI 54 myocardial infarction 54 acute leukemias 54 Gleevec resistant 54 heavily pretreated 54 Lupus nephritis 54 Evoltra ® 54 SJIA 54 acute myeloid leukemia 54 empyema 54 allogeneic stem cell 54 neutropenic patients 54 Evoltra TM 54 hepatic failure 54 chronic granulomatous disease 54 amoxicillin clavulanate 54 uncontrolled asthma 54 AFib 54 CABP 54 hypoparathyroidism 54 pancytopenia 54 homozygous familial hypercholesterolemia 54 relapsed refractory multiple myeloma 54 tyrosine kinase inhibitors TKIs 54 bone metastases 54 Torisel 54 intracerebral hemorrhage 54 eritoran 54 definite stent thrombosis 54 chronic ITP patients 54 eosinophilic asthma 54 allogeneic HSCT 54 TNF antagonist 54 chemotherapy induced neutropenia 54 myocardial infarctions 54 chronic angina 54 CIMZIA ™ 54 Chronic hepatitis B 54 recurrent genital herpes 54 acute promyelocytic leukemia APL 54 recurrent glioblastoma 54 relapsed MM 54 sustained virologic response 54 T#I [002] 54 prostate cancer CRPC 54 SCCHN 54 prostate cancer CaP 54 Bloodstream infections 54 failure ADHF 54 tolvaptan 54 cardiovascular hospitalizations 54 systolic dysfunction 54 metastatic colon cancer 54 Amigal 54 coronary intervention 54 acute PAO 54 heparin induced thrombocytopenia 54 febrile neutropenia 54 relapsing multiple sclerosis 54 hyperkalemia 54 ARIXTRA 54 stage IIIB IV 54 cinacalcet 54 Sudden Cardiac Death 54 relapsed SCLC 54 chlorambucil 54 STEMI 54 neuroendocrine cancers 54 gastric cancer 54 Acute Coronary Syndromes ACS 54 TREANDA 54 Tavocept 54 mCRC patients 53 TEMODAL 53 virologic failure 53 esophageal candidiasis 53 refractory gout 53 onset atrial fibrillation 53 antibiotic resistant bacterial infections 53 complete remissions 53 Thrombocytopenia 53 disease CDAD 53 AEG# 53 cardiac dysfunction 53 pulmonary exacerbations 53 Hemophilia B 53 Cethromycin 53 recurrent glioblastoma multiforme GBM 53 Acute renal failure 53 venous blood clots 53 chronic periodontitis 53 ribavirin therapy 53 VFEND 53 canakinumab 53 unresectable 53 diabetes mellitus DM 53 metastatic colorectal cancer 53 ADPKD 53 basiliximab 53 ACZ# 53 rilonacept 53 hemolytic anemia 53 B CLL 53 diabetic kidney 53 hyperphosphatemia 53 T1DM 53 doripenem 53 ipsilateral stroke 53 antiarrhythmic drug 53 ZOLINZA 53 Acute Decompensated Heart Failure 53 chronic kidney 53 intermittent claudication 53 locoregional 53 grade cervical dysplasia 53 vinorelbine 53 tumor lysis syndrome 53 dasatinib 53 lactic acidosis 53 Valsartan 53 KRAS mutations occur 53 relapsing remitting multiple sclerosis 53 S. aureus infection 53 symptomatic VTE 53 Noxafil 53 HuMax CD4 53 biologic therapy 53 seropositive patients 53 Cushing Syndrome 53 macroalbuminuria 53 bortezomib Velcade 53 NYHA Class III 53 nonfatal MI 53 Decitabine 53 imatinib therapy 53 Acute Coronary Syndrome 53 acquired pneumonia HAP 53 calcineurin inhibitors 53 warfarin therapy 53 nilotinib 53 bronchopulmonary dysplasia 53 multiple myeloma MM 53 pulmonary arterial hypertension PAH 53 Idiopathic Pulmonary Fibrosis 53 resistant hypertension 53 infusional 5-FU/LV 53 symptomatic BPH 53 metastatic CRC 53 evaluable subjects 53 severe neutropenia 53 interferon beta therapy 53 cIAI 53 GVHD 53 YONDELIS 53 hyperbilirubinemia 53 uncontrolled hypertension 53 COPD exacerbations 53 TAXUS Stent 53 HCV 53 pegylated liposomal doxorubicin 53 Glioblastoma Multiforme 53 Dacogen decitabine 53 post herpetic neuralgia 53 dirucotide MBP# 53 Glioblastoma 53 chemoradiotherapy 53 pertuzumab 53 PRADAXA 53 fluid overload 53 Pulmonary Arterial Hypertension PAH 53 LV dysfunction 53 ESRD 53 Severe sepsis 53 myeloproliferative neoplasms 53 Fludara ® 53 colorectal liver metastases 53 oropharyngeal candidiasis 53 post thrombotic syndrome 53 obatoclax 53 commercialize deforolimus 53 amrubicin 53 ACTEMRA TM 53 tocilizumab 53 NOMID 53 Azedra 53 gefitinib Iressa 53 ESRD patients 53 prognostic variables 53 MabCampath 53 brain tumor glioblastoma multiforme 53 carcinoid 53 thromboembolic complications 53 pleural mesothelioma 53 Gleevec imatinib 53 ankylosing spondylitis AS 53 Contrast Induced Nephropathy CIN 53 depression TRD 53 iclaprim 53 Zarnestra 53 delayed CINV 53 HNSCC 53 CYPHER Stent 53 DIPG 53 peritumoral brain edema 53 chronic myelogenous leukemia CML 53 type 1diabetes 53 topotecan 53 lymphoproliferative disorder 53 renal flares 53 surrogate endpoint 53 myelodysplastic syndromes MDS 53 adalimumab 53 decitabine 53 severe psoriasis 53 relapsed AML 53 investigational monoclonal antibody 53 advanced hepatocellular carcinoma 53 phase IIb clinical 53 carcinoid cancer 53 inhibitor RG# 53 plus dexamethasone 53 HQK 53 eribulin 53 composite endpoint 53 rheumatoid arthritis RA 53 idiopathic pulmonary fibrosis 53 ALT flares 53 rituximab Rituxan ® 53 anti leukemic 53 cell lymphoma CTCL 53 metastatic RCC 53 Zolinza 53 repeat revascularization 53 active ankylosing spondylitis 53 acute GvHD 53 brain metastases 53 chronic myocardial ischemia 53 Campath alemtuzumab 53 MACCE 53 MGUS 53 imatinib mesylate Gleevec 53 Systemic Lupus Erythematosus 53 CIMZIA TM 53 cirrhosis liver failure 53 GRNOPC1 cells 53 CANCIDAS 53 daptomycin 52 pediatric acute lymphoblastic 52 ventricular arrhythmia 52 calcineurin inhibitor 52 FOLOTYN 52 systemic lupus erythematosus 52 antithrombotics 52 Acute Myeloid Leukemia AML 52 hereditary antithrombin deficiency 52 transplantation HCT 52 cutaneous T 52 CRBSI 52 monotherapy 52 clinically localized prostate 52 tiotropium 52 R0 resection 52 post herpetic neuralgia PHN 52 overt nephropathy 52 nephrotoxicity 52 homozygous FH 52 purpura ITP 52 metastatic renal cell 52 pediatric Crohn disease 52 relapsing remitting 52 Metastatic breast cancer 52 Chronic Heart Failure 52 oral FTY# 52 ALI ARDS 52 refractory epilepsy 52 PCNSL 52 Idiopathic pulmonary fibrosis 52 myocardial infarction ventricular fibrillation 52 revascularization procedures 52 chronic hepatitis B. 52 myelodysplastic syndromes 52 infective endocarditis 52 diabetic neuropathic pain 52 preserved ejection fraction 52 platelet reactivity 52 XIENCE V PROMUS Stent 52 risk stratification 52 TNF inhibitor therapy 52 gouty arthritis 52 MGd 52 lymphoblastic leukemia 52 cardiovascular morbidity 52 malignancies 52 rotavirus gastroenteritis 52 complete cytogenetic response 52 hemophilia B. 52 Omacetaxine 52 Arcalyst 52 recurrent venous thromboembolism 52 registrational 52 juvenile idiopathic arthritis 52 arterial thrombosis 52 interstitial lung disease 52 skeletal metastases 52 metastatic prostate cancer 52 adverse cytogenetics 52 sunitinib malate 52 bivalirudin 52 OncoVEX GM CSF 52 SUTENT 52 intensive statin therapy 52 paroxysmal nocturnal hemoglobinuria PNH 52 sJIA 52 Natalizumab 52 mycosis fungoides 52 pericardial effusion 52 Halaven 52 Jevtana 52 unresectable stage 52 erlotinib Tarceva ® 52 daclizumab 52 hyperphenylalaninemia HPA due 52 HBeAg negative 52 liver transplantations 52 Navelbine ® 52 tesmilifene 52 Hodgkin lymphoma HL 52 C. difficile infections 52 dose cytarabine 52 Pemetrexed 52 herpes zoster 52 bevacizumab Avastin ® 52 osteoporotic fractures 52 Severe Primary IGFD 52 eosinophilic pneumonia 52 posterior uveitis 52 Gleevec imatinib mesylate 52 metastatic disease 52 glioblastoma multiforme GBM 52 Host Disease GvHD 52 vemurafenib 52 postoperative morbidity 52 basal cell carcinoma BCC 52 Ribavirin causes 52 dacarbazine 52 squamous cell lung cancer 52 Symadex 52 Onrigin 52 G CSF 52 cabazitaxel 52 CMV retinitis 52 relapsing remitting MS 52 ELACYT 52 certolizumab 52 systemic scleroderma 52 recurrent glioma 52 HER2 positive metastatic breast 52 smoldering multiple myeloma 52 Chronic Myelogenous Leukemia CML 52 Allovectin 7 52 anaphylaxis 52 non Hodgkin Lymphoma 52 peginterferon alfa 2a 52 cytomegalovirus infection 52 gastrointestinal malignancies 52 hour bronchodilation 52 Ceflatonin 52 CLL 52 Mucositis 52 Hydroxyurea 52 Azilect ® 52 plus gemcitabine 52 mycophenolate mofetil 52 posaconazole 52 eplerenone 52 CYT# potent vascular disrupting 52 Evoltra 52 xanthine oxidase inhibitor 52 relapsed ovarian cancer 52 rebleeding 52 Myelodysplastic Syndrome 52 Mozobil 52 Clolar 52 Insegia 52 differentiated thyroid 52 nesiritide 52 prostate cancer PCa 52 TTR amyloidosis 52 gastrointestinal stromal tumor GIST 52 antihypertensive therapy 52 receptor tyrosine kinase inhibitor 52 SCH # 52 PNH patients 52 Tekamlo 52 VAPRISOL 52 severe hypoglycemia 52 relapsed CLL 52 sargramostim 52 null responder HCV 52 antihypertensive agents 52 CIPN 52 systolic hypertension 52 systemic mastocytosis 52 acid suppressive medication 52 mixed dyslipidemia 52 relapsed GBM 52 TMP SMX 52 mildly symptomatic 52 Non Hodgkin Lymphoma 52 sorafenib Nexavar 52 ISTODAX 52 methicillin resistant S. aureus 52 trabectedin 52 refractory CLL 52 pegfilgrastim 52 tumor recurrence 52 recurrent NSCLC 52 Pegasys ® 52 simplex virus 52 apricitabine 52 severe asthma exacerbations 52 demyelinating 52 Toxicities 52 neutropenic fever 52 diabetic retinopathy DR 52 HBeAg positive patients 52 bevacizumab Avastin 52 IBS C 52 dasatinib Sprycel ® 52 venous thromboembolism 52 herpes zoster shingles 52 lomitapide 52 exacerbations 52 interferon therapy 52 Angiox R 52 soft tissue sarcomas 52 sarcomas 52 Neutropenia 52 systemic corticosteroids 52 sudden cardiac death 52 juvenile idiopathic arthritis JIA 52 irinotecan chemotherapy 52 pegylated interferon alpha 52 atherothrombosis 52 riociguat 52 cytogenetic responses 52 dose cohorts 52 myeloid leukemia 52 ischemic strokes 52 follicular lymphoma FL 52 severe rotavirus gastroenteritis 52 BRAF inhibitor 52 pain palliation 52 tachyarrhythmias 52 pediatric malignancies 52 lupus renal disease 52 malignant neoplasm 52 cardiac resynchronization 52 nucleotide analog 52 invasive cervical cancer 52 chronic hepatitis cirrhosis 52 viral kinetics 52 patients undergoing percutaneous 52 Cloretazine 52 chronic eosinophilic leukemia 52 hemolytic uremic syndrome HUS 52 tafamidis 52 TORISEL 52 sustained ventricular tachycardia 52 necrotizing pancreatitis 52 pirfenidone 52 Pulmonary arterial hypertension 52 Aspergillus infections 52 CHOP chemotherapy 52 cangrelor 52 Waldenstrom macroglobulinemia 52 cutaneous T cell 52 metastatic uveal melanoma 52 Rituximab 52 Crohn disease 52 chronic hemodialysis 52 panitumumab 52 DVT PE 52 Irinotecan 52 Retreatment 52 chronic hepatitis C 52 elacytarabine 52 myeloproliferative disorders 52 Myelodysplastic syndromes MDS 52 atherothrombotic 52 LQTS 52 HER2 positive 52 MDR TB 51 Chronic hepatitis C 51 malignant pleural mesothelioma MPM 51 status asthmaticus 51 CoFactor 51 Acute Myocardial Infarction AMI 51 sorafenib Nexavar ® 51 hepatic encephalopathy 51 ST elevation myocardial 51 TMS Therapy 51 VaD 51 Adjuvant chemotherapy 51 hematological cancers 51 Epratuzumab 51 Stomach cancer 51 fragility fractures 51 ATTR PN 51 Mipomersen 51 Revlimid lenalidomide 51 immunocompetent 51 inhaled corticosteroid therapy 51 Dacogen 51 PRT# 51 MDR tuberculosis 51 TAXUS stent 51 Acute Myeloid Leukemia 51 Catena ® 51 Trastuzumab 51 generalized edema 51 myelofibrosis polycythemia vera 51 Fibrin Pad 51 pyelonephritis 51 relapsed refractory 51 cSSSIs 51 darapladib 51 chronic plaque psoriasis 51 imipenem 51 minimally symptomatic 51 advanced metastatic prostate 51 acute gout flares 51 ARCOXIA 51 antithrombotic therapies 51 G#DT 51 ventricular fibrillation VF 51 cerebral vasospasm 51 infections cIAI 51 patients undergoing CABG 51 nosocomial infections 51 Sezary syndrome 51 Hereditary angioedema HAE 51 primary immunodeficiency 51 cytoreduction 51 chemoradiation 51 pheochromocytoma 51 lipid lowering therapy 51 sustained virological response 51 unstable angina UA 51 LHON 51 recurrent ischemia 51 chronic myeloid leukemia CML 51 Genentech Rituxan 51 sorafenib 51 Vidaza azacitidine 51 epithelial tumors 51 renal disease 51 OPAXIO 51 recurrent wheezing 51 grade glioma 51 Epoetin alfa 51 non valvular atrial 51 coronary revascularization procedures 51 Ulcerative colitis 51 immune thrombocytopenic purpura 51 Severe sepsis afflicts 51 Glioblastoma multiforme 51 Vandetanib 51 hormone refractory 51 Adalimumab 51 ribavirin RBV 51 chronic hepatitis B 51 Motavizumab 51 Bronchitol 51 debilitating autoimmune 51 chronic immune thrombocytopenic 51 PSADT 51 Aviptadil 51 LHRH antagonists 51 glioblastoma 51 mechanically ventilated patients 51 Chronic Myeloid Leukemia 51 Kepivance 51 ALN TTR# 51 stage IIIB 51 Kit CD# positive 51 synthetic retinoid 51 androgen deprivation 51 evaluating REVLIMID 51 relapsing MS 51 Cachexia 51 romiplostim 51 colectomy 51 C1 INH 51 gemcitabine chemotherapy 51 pancreatic neuroendocrine tumors 51 angioedema 51 advanced NSCLC 51 Vaprisol 51 belinostat 51 ganciclovir 51 limb ischemia 51 fluvastatin 51 Mylotarg 51 pharmacologic intervention 51 thrombolytic agents 51 bacteremia 51 oral anticoagulant 51 Dacogen injection 51 neutropenic 51 Xanafide 51 Non inferiority 51 Taxotere ® 51 intracranial hemorrhage ICH 51 antiviral therapy 51 HAIs 51 taxane therapy 51 C difficile infection 51 velafermin 51 antiepileptic drug 51 Follicular Lymphoma 51 FluCAM arm 51 cardiovascular mortality 51 epilepsies 51 EGFR inhibitors 51 mutated KRAS gene 51 either acutely decompensated 51 methylnaltrexone 51 antiplatelet agents 51 ACTEMRA 51 thromboembolism 51 CTAP# Capsules 51 cardio renal 51 hypertensive patients 51 cytopenias 51 systemic ALCL 51 refractory ischemia 51 gastrointestinal stromal tumors GIST 51 ON #.Na 51 Fludara 51 Removab 51 antithrombotic agents 51 status epilepticus 51 antibody MAb 51 streptokinase 51 Actimmune ® 51 solid tumors 51 reperfusion injury 51 StaphVAX 51 refractory metastatic colorectal cancer 51 acromegalic patients 51 primary hypercholesterolemia 51 BSIs 51 coronary artery disease 51 metastatic bladder 51 ATTR CM 51 Plicera 51 INCB# [003] 51 peginterferon 51 Hepatitis C HCV 51 thalidomide Thalomid 51 CLL SLL 51 pneumococcal infections 51 sapacitabine 51 generalized seizures 51 lung fibrosis 51 atrial fibrillation 51 Bezielle 51 acute bacterial sinusitis 51 metastatic neuroendocrine tumors 51 β blockers 51 AAT Deficiency 51 CTEPH 51 argatroban 51 ATIR 51 Traficet EN 51 gastric adenocarcinoma 51 Lupus Nephritis 51 APTIVUS r 51 hemorrhagic complications 51 debilitating complication 51 basal cell nevus syndrome 51 COPAXONE R 51 decompensated liver disease 51 hepatitis C virus 51 unresectable liver cancer 51 indolent lymphomas 51 variceal bleeding 51 dengue haemorrhagic fever DHF 51 oral ridaforolimus 51 ADEs 51 hyperphosphataemia 51 octreotide LAR 51 antithrombotic 51 glycated hemoglobin levels 51 Parkinson disease PD 51 STEMI patients 51 P. aeruginosa infections 51 opioid induced constipation OIC 51 chemotherapy induced thrombocytopenia 51 IPAH 51 HIV HCV coinfected 51 Nilotinib 51 cell lymphomas 51 metastatic castration resistant 51 primary immunodeficiency PI 51 anaplastic thyroid cancer 51 visilizumab 51 Gemzar ® 51 Nexavar sorafenib 51 acute rheumatic fever 51 constipation OIC 51 Certican 51 maribavir 51 haematological malignancies 51 postherpetic neuralgia 51 hypercalcemia 51 HCV genotype 1 51 ranolazine 51 NGAL 51 IV melanoma 51 corticosteroid therapy 51 platinum refractory 51 TAXUS Liberte stent 51 HCV infected 51 asthma exacerbations 51 endotoxemia 51 Restanza 51 chronic idiopathic thrombocytopenic purpura 51 de aths 51 cachexia 51 MYDICAR 51 Myelofibrosis 51 IPL# 51 soft tissue sarcoma 51 neuroendocrine tumors 51 EndoTAG TM -1 51 neurologic complications 51 endophthalmitis 51 Lactic acidosis 51 nonmelanoma skin cancers 51 progressive PsA 51 NSTE ACS 51 disease COPD 51 infliximab Remicade 51 YERVOY 51 alvespimycin 51 Laquinimod 51 BEXXAR 51 aortic valve stenosis 51 chronic hepatitis 51 hypercholesterolaemia 51 partial onset seizures 51 Wilms tumor

Back to home page